EATG » PrEP

PrEP

Latest issue of Journal of Virus Eradication now online

The Journal of Virus Eradication provides a specialist, open-access forum and fast-track pathway to publish work in the rapidly developing field of virus eradication, particularly of HIV, HBV and HCV.…

First US failure of Truvada as PrEP is reported at IDWeek 2018

A poster presentation at IDWeek, a yearly conference held by the Infectious Diseases Society of America, revealed that a 21-year-old Latinx man has acquired HIV despite consistently high adherence to…

Ireland: HIV prevention drug PrEP to be evaluated for State funding

Hiqa has began assessment to examine cost and clinical effectiveness of supply Health authorities have begun a formal process to evaluate the possibility of introducing a State-funded HIV prevention drug.…

PrEP regarded as a social problem by some gay and bisexual men

Gay and bisexual men have differing attitudes towards men who are using pre-exposure prophylaxis (PrEP), according to US research published in Sociology of Health & Illness. A series of focus…

Most PrEP users in Berlin obtained it from informal channels

Over half of men who have sex with men (MSM) living in Berlin who were using HIV pre-exposure prophylaxis (PrEP) accessed it through informal sources, without consistent medical monitoring, according…

Making clinical trials of PrEP more inclusive of women, no matter their pregnancy status

Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs…

HIV i-Base: HIV Treatment Bulletin, 19 September 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. In this issue of HTB: results from the UK HIV surveillance programme; AIDS 2018 – third reports; the…

PrEP not tied to drug resistance

HIV-negative men who receive pre-exposure prophylaxis (PrEP) with tenofovir (TDF) and emtricitabine (FTC) do not develop resistance to these drugs, according to new findings from the IPERGAY ANRS trial. The…

HIV treatment in Malta archaic, activist warns

Medication comes at a hefty price of €600 Treatment for human immunodeficiency virus (HIV) in Malta is “archaic” because doctors were prescribing “outdated” drug regiments, HIV awareness activist Mark Josef Rapa has…

US doctors’ organisation endorses event-based PrEP for the first time

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP) as an alternative to daily dosing. The International Antiviral Society-USA…

1 2 3 35